{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:08:13Z","timestamp":1794744493825,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007065","name":"Universit\u00e0 degli Studi di Salerno","doi-asserted-by":"publisher","award":["FARB 2020, 2021"],"award-info":[{"award-number":["FARB 2020, 2021"]}],"id":[{"id":"10.13039\/501100007065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Altergon Italia Srl","award":["Contratto di sviluppo CDS 000463"],"award-info":[{"award-number":["Contratto di sviluppo CDS 000463"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Skin wound healing requires accurate therapeutic topical managements to accelerate tissue regeneration. Here, for the first time, we found that the association mesoglycan\/VEGF has a strong pro-healing activity. In detail, this combination induces angiogenesis in human endothelial cells promoting in turn fibroblasts recruitment. These ones acquire a notable ability to invade the matrigel coating and to secrete an active form of metalloproteinase 2 in presence of endothelial cells treated with mesoglycan\/VEGF. Next, by creating intrascapular lesions on the back of C57Bl6 mice, we observed that the topical treatments with the mesoglycan\/VEGF promotes the closure of wounds more than the single substances beside the control represented by a saline solution. As revealed by eosin\/hematoxylin staining of mice skin biopsies, treatment with the combination mesoglycan\/VEGF allows the formation of a well-structured matrix with a significant number of new vessels. Immunofluorescence analyses have revealed the presence of endothelial cells at the closed region of wounds, as evaluated by CD31, VE-cadherin and fibronectin staining and of activated fibroblasts assessed by vimentin, col1A and FAP1\u03b1. These results encourage defining the association mesoglycan\/VEGF to activate endothelial and fibroblast cell components in skin wound healing promoting the creation of new vessels and the deposition of granulation tissue.\n<\/jats:p>","DOI":"10.1038\/s41598-022-15227-1","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T09:03:51Z","timestamp":1656579831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The combination of mesoglycan and VEGF promotes skin wound repair by enhancing the activation of endothelial cells and fibroblasts and their cross-talk"],"prefix":"10.1038","volume":"12","author":[{"given":"Raffaella","family":"Belvedere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia","family":"Novizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"15227_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4103\/2347-9264.165448","volume":"2","author":"TM Honnegowda","year":"2015","unstructured":"Honnegowda, T. M. et al. Role of angiogenesis and angiogenic factors in acute and chronic wound healing. Plast. Aesthet. Res. 2, 243\u2013249 (2015).","journal-title":"Plast. Aesthet. Res."},{"key":"15227_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000339613","volume":"49","author":"JM Reinke","year":"2012","unstructured":"Reinke, J. M. & Sorg, H. Wound repair and regeneration. Eur. Surg. Res. 49, 35\u201343 (2012).","journal-title":"Eur. Surg. Res."},{"key":"15227_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1046\/j.1087-0024.2000.00014.x","volume":"5","author":"MG Tonnesen","year":"2000","unstructured":"Tonnesen, M. G., Feng, X. & Clark, R. A. Angiogenesis in wound healing. J. Investig. Dermatol. Symp. Proc. 5, 40\u201346 (2000).","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"15227_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/pharmaceutics13020193","volume":"13","author":"NIM Fadilah","year":"2021","unstructured":"Fadilah, N. I. M., Rahman, M. B. A., Yusof, L. M., Mustapha, N. M. & Ahmad, H. The therapeutic effect and in vivo assessment of Palmitoyl-GDPH on the wound healing process. Pharmaceutics 13, 193 (2021).","journal-title":"Pharmaceutics"},{"key":"15227_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1189\/jlb.4MR0316-102R","volume":"100","author":"LA Di Pietro","year":"2016","unstructured":"Di Pietro, L. A. Angiogenesis and wound repair: When enough is enough. J. Leukoc. Biol. 100, 979\u2013984 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"15227_CR6","doi-asserted-by":"publisher","first-page":"e0231962","DOI":"10.1371\/journal.pone.0231962","volume":"15","author":"UA Okonkwo","year":"2020","unstructured":"Okonkwo, U. A. et al. Compromised angiogenesis and vascular integrity in impaired diabetic wound healing. PLoS ONE 15, e0231962 (2020).","journal-title":"PLoS ONE"},{"key":"15227_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1468-3083.2011.04415.x","volume":"26","author":"B Behm","year":"2012","unstructured":"Behm, B., Babilas, P., Landthaler, M. & Schreml, S. Cytokines, chemokines and growth factors in wound healing. J. Eur. Acad. Dermatol. Venereol. 26, 812\u2013820 (2012).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"15227_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/molecules22081259","volume":"22","author":"JW Park","year":"2017","unstructured":"Park, J. W., Hwang, S. R. & Yoon, I. S. Advanced growth factor delivery systems in wound management and skin regeneration. Molecules 22, 1259 (2017).","journal-title":"Molecules"},{"key":"15227_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/wound.2013.0517","volume":"3","author":"KE Johnson","year":"2014","unstructured":"Johnson, K. E. & Wilgus, T. A. Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Adv. Wound Care 3, 647\u2013661 (2014).","journal-title":"Adv. Wound Care"},{"key":"15227_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jss.2008.04.023","volume":"153","author":"P Bao","year":"2009","unstructured":"Bao, P. et al. The role of vascular endothelial growth factor in wound healing. J. Surg. Res. 153, 347\u2013358 (2009).","journal-title":"J. Surg. Res."},{"key":"15227_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","volume":"16","author":"S Barrientos","year":"2018","unstructured":"Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H. & Tomic-Canic, M. Growth factors and cytokines in wound healing. Wound Repair Regen. 16, 585\u2013601 (2018).","journal-title":"Wound Repair Regen."},{"key":"15227_CR12","doi-asserted-by":"publisher","first-page":"9351","DOI":"10.1016\/j.actbio.2013.07.030","volume":"9","author":"Z Xie","year":"2013","unstructured":"Xie, Z. et al. Dual growth factor releasing multi-functional nanofibers for wound healing. Acta Biomater. 9, 9351\u20139359 (2013).","journal-title":"Acta Biomater."},{"key":"15227_CR13","first-page":"168","volume":"12","author":"R Belvedere","year":"2018","unstructured":"Belvedere, R., Bizzarro, V., Parente, L., Petrella, F. & Petrella, A. Effects of Prisma\u00ae Skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts. Cell Adhesion Migr. 12, 168\u2013183 (2018).","journal-title":"Cell Adhesion Migr."},{"key":"15227_CR14","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1002\/jcp.30207","volume":"236","author":"R Belvedere","year":"2021","unstructured":"Belvedere, R. et al. Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2. J. Cell Physiol. 236, 4926\u20134943 (2021).","journal-title":"J. Cell Physiol."},{"key":"15227_CR15","doi-asserted-by":"publisher","first-page":"20174","DOI":"10.1002\/jcp.28618","volume":"234","author":"V Bizzarro","year":"2019","unstructured":"Bizzarro, V. et al. Mesoglycan induces keratinocyte activation by triggering syndecan-4 pathway and the formation of the annexin A1\/S100A11 complex. J. Cell Physiol. 234, 20174\u201320192 (2019).","journal-title":"J. Cell Physiol."},{"key":"15227_CR16","doi-asserted-by":"publisher","first-page":"7532019","DOI":"10.3390\/cells8070753","volume":"8","author":"E Pessolano","year":"2019","unstructured":"Pessolano, E. et al. Annexin A1 contained in extracellular vesicles promotes the activation of keratinocytes by mesoglycan effects: An autocrine loop through FPRs. Cells 8, 7532019 (2019).","journal-title":"Cells"},{"key":"15227_CR17","doi-asserted-by":"publisher","first-page":"172894","DOI":"10.1016\/j.ejphar.2019.172894","volume":"869","author":"R Belvedere","year":"2020","unstructured":"Belvedere, R. et al. Mesoglycan induces the secretion of microvesicles by keratinocytes able to activate human fibroblasts and endothelial cells: A novel mechanism in skin wound healing. Eur. J. Pharmacol. 869, 172894 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"15227_CR18","doi-asserted-by":"publisher","first-page":"104711","DOI":"10.1016\/j.supflu.2019.104711","volume":"157","author":"P Franco","year":"2020","unstructured":"Franco, P., Pessolano, E., Belvedere, R., Petrella, A. & De Marco, I. Supercritical impregnation of mesoglycan into calcium alginate aerogel for wound healing. J. Supercrit. Fluids. 157, 104711 (2020).","journal-title":"J. Supercrit. Fluids."},{"key":"15227_CR19","first-page":"20","volume":"1","author":"F Petrella","year":"2020","unstructured":"Petrella, F. et al. A new pharmaceutical device containing mesoglycan modulates fibroblasts function in vivo. Pharmacologyonline. 1, 20\u201330 (2020).","journal-title":"Pharmacologyonline."},{"key":"15227_CR20","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/ijms18081614","volume":"18","author":"R Belvedere","year":"2017","unstructured":"Belvedere, R., Bizzarro, V., Parente, L., Petrella, F. & Petrella, A. The pharmaceutical device Prisma\u00ae Skin promotes in vitro angiogenesis through endothelial to mesenchymal transition during skin wound healing. Int. J. Mol. Sci. 18, 1614 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"15227_CR21","doi-asserted-by":"publisher","first-page":"105886","DOI":"10.1016\/j.ejps.2021.105886","volume":"163","author":"R Belvedere","year":"2021","unstructured":"Belvedere, R. et al. The promising pro-healing role of the association of mesoglycan and lactoferrin on skin lesions. Eur. J. Pharm. Sci. 163, 105886 (2021).","journal-title":"Eur. J. Pharm. Sci."},{"key":"15227_CR22","doi-asserted-by":"publisher","first-page":"6428","DOI":"10.1111\/febs.16043","volume":"288","author":"E Pessolano","year":"2021","unstructured":"Pessolano, E. et al. Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro. FEBS J. 288, 6428\u20136446 (2021).","journal-title":"FEBS J."},{"key":"15227_CR23","first-page":"212","volume":"5","author":"K Kr\u00f6ger","year":"2012","unstructured":"Kr\u00f6ger, K., Dissemond, J., Storck, M., Risse, A. & Engels, P. Chronic wounds: Hypoxia prevents healing!. Wound Manag. 5, 212\u2013217 (2012).","journal-title":"Wound Manag."},{"key":"15227_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7603\/s40681-015-0022-9","volume":"5","author":"S Dhivya","year":"2015","unstructured":"Dhivya, S., Padma, V. V. & Santhini, E. Wound dressings\u2014A review. Biomedicine 5, 22 (2015).","journal-title":"Biomedicine"},{"key":"15227_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1152\/physrev.00067.2017","volume":"99","author":"M Rodrigues","year":"2019","unstructured":"Rodrigues, M., Kosaric, N., Bonham, C. A. & Gurtner, G. C. Wound healing: A cellular perspective. Physiol. Rev. 99, 665\u2013706 (2019).","journal-title":"Physiol. Rev."},{"key":"15227_CR26","first-page":"588","volume":"43","author":"G Sussman","year":"2014","unstructured":"Sussman, G. Ulcer dressings and management. Aust. Fam. Physician. 43, 588\u2013592 (2014).","journal-title":"Aust. Fam. Physician."},{"key":"15227_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10456-017-9563-8","volume":"20","author":"CJ Turner","year":"2017","unstructured":"Turner, C. J., Badu-Nkansah, K. & Hynes, R. O. Endothelium-derived fibronectin regulates neonatal vascular morphogenesis in an autocrine fashion. Angiogenesis 20, 519\u2013531 (2017).","journal-title":"Angiogenesis"},{"key":"15227_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.addr.2020.09.005","volume":"170","author":"J Patten","year":"2020","unstructured":"Patten, J. & Wang, K. Fibronectin in development and wound healing. Adv. Drug Deliv. Rev. 170, 353\u2013368 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"15227_CR29","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1038\/s41598-017-03614-y","volume":"7","author":"MB Johnson","year":"2017","unstructured":"Johnson, M. B. et al. Topical fibronectin improves wound healing of irradiated skin. Sci. Rep. 7, 3876 (2017).","journal-title":"Sci. Rep."},{"key":"15227_CR30","doi-asserted-by":"publisher","first-page":"100ra89","DOI":"10.1126\/scitranslmed.3002614","volume":"3","author":"MM Martino","year":"2011","unstructured":"Martino, M. M. et al. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 3, 100ra89 (2011).","journal-title":"Sci. Transl. Med."},{"key":"15227_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/bioengineering8050063","volume":"8","author":"SS Mathew-Steiner","year":"2021","unstructured":"Mathew-Steiner, S. S., Roy, S. & Sen, C. K. Collagen in wound healing. Bioengineering 8, 63 (2021).","journal-title":"Bioengineering"},{"key":"15227_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.22467\/jwmr.2019.00640","volume":"15","author":"HJ Yang","year":"2019","unstructured":"Yang, H. J. & Kang, S. Y. The clinical uses of collagen-based matrices in the treatment of chronic wounds. J. Wound Manag. Res. 15, 103\u2013108 (2019).","journal-title":"J. Wound Manag. Res."},{"key":"15227_CR33","first-page":"A30","volume":"15","author":"OKA Stojadinovic","year":"2007","unstructured":"Stojadinovic, O. K. A., Golinko, M., Tomic-Canic, M. & Brem, H. A novel, non-angiogenic mechanism of VEGF: Stimulation of keratinocyte and fibroblast migration. Wound Repair Regen. 15, A30 (2007).","journal-title":"Wound Repair Regen."},{"key":"15227_CR34","doi-asserted-by":"publisher","first-page":"13505","DOI":"10.1073\/pnas.0906670106","volume":"106","author":"H Thangarajah","year":"2009","unstructured":"Thangarajah, H. et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc. Natl. Acad. Sci. USA 106, 13505\u201313510 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"15227_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12079-015-0300-z","volume":"9","author":"KM Gutpell","year":"2015","unstructured":"Gutpell, K. M. & Hoffman, L. M. VEGF induces stress fiber formation in fibroblasts isolated from dystrophic muscle. J. Cell Commun. Signal. 9, 353\u2013360 (2015).","journal-title":"J. Cell Commun. Signal."},{"key":"15227_CR36","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1161\/CIRCULATIONAHA.120.050875","volume":"142","author":"NG Frangogiannis","year":"2020","unstructured":"Frangogiannis, N. G. Fact and fiction about fibroblast to endothelium conversion: Semantics and substance of cellular identity. Circulation 142, 1663\u20131666 (2020).","journal-title":"Circulation"},{"key":"15227_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fcell.2019.00044","volume":"7","author":"B Sanchez","year":"2019","unstructured":"Sanchez, B. et al. Impact of human dermal microvascular endothelial cells on primary dermal fibroblasts in response to inflammatory stress. Front. Cell Dev. Biol. 7, 44 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"15227_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/pharmaceutics12080735","volume":"12","author":"EM Tottoli","year":"2020","unstructured":"Tottoli, E. M. et al. Skin wound healing process and new emerging technologies for skin wound care and regeneration. Pharmaceutics. 12, 735 (2020).","journal-title":"Pharmaceutics."},{"key":"15227_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42490-019-0018-8","volume":"1","author":"HN Monsuur","year":"2019","unstructured":"Monsuur, H. N., Weijers, E. M., Gibbs, S. & van den Broek, L. J. Skin substitutes are more potent than dermal or epidermal substitutes in stimulating endothelial cell sprouting. BMC Biomed. Eng. 1, 18 (2019).","journal-title":"BMC Biomed. Eng."},{"key":"15227_CR40","doi-asserted-by":"publisher","first-page":"903","DOI":"10.7150\/ijms.44188","volume":"17","author":"JW Zhu","year":"2020","unstructured":"Zhu, J. W. et al. Tranexamic acid inhibits angiogenesis and melanogenesis in vitro by targeting VEGF receptors. Int. J. Med. Sci. 17, 903\u2013911 (2020).","journal-title":"Int. J. Med. Sci."},{"key":"15227_CR41","doi-asserted-by":"publisher","first-page":"114252","DOI":"10.1016\/j.bcp.2020.114252","volume":"182","author":"R Belvedere","year":"2020","unstructured":"Belvedere, R. et al. Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells. Biochem. Pharmacol. 182, 114252 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"15227_CR42","doi-asserted-by":"publisher","first-page":"11018","DOI":"10.3390\/ijms222011018","volume":"22","author":"N Novizio","year":"2021","unstructured":"Novizio, N. et al. ANXA1 contained in EVs regulates macrophage polarization in tumor microenvironment and promotes pancreatic cancer progression and metastasis. Int. J. Mol. Sci. 22, 11018 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"15227_CR43","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/cells9122719","volume":"9","author":"N Novizio","year":"2020","unstructured":"Novizio, N. et al. Annexin A1 released in extracellular vesicles by pancreatic cancer cells activates components of the tumor microenvironment, through interaction with the formyl-peptide receptors. Cells 9, 2719 (2020).","journal-title":"Cells"},{"key":"15227_CR44","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1161\/hq1201.099432","volume":"21","author":"YX Suya","year":"2001","unstructured":"Suya, Y. X. et al. Vascular endothelial cell growth factor driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain containing receptor. Arterioscler. Thromb. Vasc. Biol. 21, 1934\u20131940 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"15227_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4103\/0253-7613.132152","volume":"46","author":"WH AlMalki","year":"2014","unstructured":"AlMalki, W. H., Shahid, I., Mehdi, A. Y. & Hafeez, M. H. Assessment methods for angiogenesis and current approaches for its quantification. Indian J. Pharmacol. 46, 251\u2013256 (2014).","journal-title":"Indian J. Pharmacol."},{"key":"15227_CR46","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nprot.2013.002","volume":"8","author":"X Wang","year":"2013","unstructured":"Wang, X., Ge, J., Tredget, E. E. & Wu, Y. The mouse excisional wound splinting model, including applications for stem cell transplantation. Nat. Protoc. 8, 302\u2013309 (2013).","journal-title":"Nat. Protoc."},{"key":"15227_CR47","doi-asserted-by":"publisher","first-page":"29660","DOI":"10.1038\/srep29660","volume":"6","author":"R Belvedere","year":"2016","unstructured":"Belvedere, R. et al. Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway. Sci. Rep. 6, 29660 (2016).","journal-title":"Sci. Rep."},{"key":"15227_CR48","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3390\/ijms19071967","volume":"19","author":"R Belvedere","year":"2018","unstructured":"Belvedere, R. et al. miR-196a is able to restore the aggressive phenotype of annexin A1 knock-out in pancreatic cancer cells by CRISPR\/Cas9 genome editing. Int. J. Mol. Sci. 19, 1967 (2018).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15227-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15227-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15227-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:02:42Z","timestamp":1669356162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15227-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15227"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15227-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"7 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11041"}}